September 22-25, 2026
Hynes Convention CenterBoston, USA Paul RousseauSr. Engineer II, Cell Line Development at BiogenSpeaker
Profile
Paul is a chemical engineer who graduated from Northeastern University in May of 2016. Since then, Paul has been at Biogen for 10 years within the Proteins Development organization, working in upstream process development, as well as cell line development. In both roles, Paul has worked on early and late stage clinical development of monoclonal antibodies, including multi-specifics, as well as various technology initiatives to improve platforms for future projects.
Agenda Sessions
Rational Vector Design and Screening Strategies for Bispecific Cell Line Development via Random Integration
, 9:30amView Session